Unlock instant, AI-driven research and patent intelligence for your innovation.

A kind of anticancer drug compound and its preparation method and application

An anti-cancer drug and compound technology, applied in the biological field, can solve the problems of reduced efficacy of chemotherapeutic drugs, multidrug resistance of tumors, multi-targets, etc. Effect

Active Publication Date: 2021-06-01
NINGBO INST OF MATERIALS TECH & ENG CHINESE ACADEMY OF SCI
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

But these drugs are often multi-targeted and have significant side effects
In addition, long-term use of antineoplastic drugs will also cause multidrug resistance of tumors, and the efficacy of chemotherapy drugs will be reduced or invalid.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of anticancer drug compound and its preparation method and application
  • A kind of anticancer drug compound and its preparation method and application
  • A kind of anticancer drug compound and its preparation method and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0046] Follow the steps below to synthesize anticancer drug complexes

[0047] According to the molar ratio of 1:2:0.001, zinc acetate dihydrate, 2-imidazole formaldehyde and doxorubicin were successively weighed and placed in a dry hammer bottle, dissolved in an equal volume of N,N-dimethylformamide to prepare Solution, wherein the concentration of zinc acetate dihydrate is 0.2 moles per liter. After the dissolution is completed, take 2 milliliters and mix each, avoid light, and shake at room temperature at 100rpm on a shaker for 1h. After centrifuging to remove the supernatant, the product is vacuum-dried. ZIF-90@doxorubicin.

[0048] Weigh [Arg 6 ,Pro 34 ]pNPY and ZIF-90@doxorubicin were placed in a dry Erlenmeyer flask, then an equal volume of methanol was added, ultrasonicated to form a transparent solution, mixed and stirred in the dark for 48 hours, and the mixed solution of methanol and ethanol with a volume ratio of 20:1 was used to High-speed centrifugal washing, ...

Embodiment 2

[0050] Follow the steps below to synthesize anticancer drug complexes

[0051] According to the molar ratio of 1:1:0.005, zinc acetate, 2-imidazole formaldehyde and cisplatin were successively weighed and placed in a dry hammer bottle, dissolved in an equal volume of N,N-dimethylformamide to prepare a solution, wherein , the concentration of zinc acetate is 0.2 moles per liter. After the dissolution is completed, take 2 ml each to mix, avoid light, and shake at room temperature at 100 rpm on a shaker for 1 hour. After the supernatant is removed by centrifugation, the vacuum-dried product is ZIF-90@通 platinum.

[0052] According to the mass ratio of 1:100, weigh [Arg 6 ,Pro 34 ]pNPY and ZIF-90@cisplatin in a dry Erlenmeyer flask, add an equal volume of methanol, sonicate to form a transparent solution, mix and stir for 12 hours in the dark, and use a mixed solution with a volume ratio of methanol and ethanol of 20:1 for ultra-high speed After centrifugal washing and vacuum dr...

Embodiment 3

[0054] Follow the steps below to synthesize anticancer drug complexes

[0055] According to the molar ratio of 1:5:0.05, zinc acetate hexahydrate, 2-imidazole formaldehyde and vincristine were successively weighed and placed in a dry hammer bottle, dissolved in an equal volume of N,N-dimethylformamide to prepare solution, wherein the concentration of zinc acetate hexahydrate is 0.2 moles per liter, after the dissolution is completed, each take 2 milliliters to mix, avoid light, at room temperature, shake at 100rpm on a shaker for 1h, centrifuge to remove the supernatant and then vacuum dry the product. ZIF-90@vincristine.

[0056] Weigh [Phe 6 ,Pro 34 ]pNPY and ZIF-90@vincristine were placed in a dry Erlenmeyer flask, then an equal volume of methanol was added, ultrasonicated to form a transparent solution, mixed and stirred in the dark for 48 hours, and the mixed solution with a volume ratio of methanol and ethanol of 20:1 was used to High-speed centrifugal washing, vacuum...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
particle sizeaaaaaaaaaa
Login to View More

Abstract

The invention discloses an anticancer drug complex, which has a core-shell structure, wherein the core of the core-shell structure is an anticancer active component, and the shell of the core-shell structure is composed of neuropeptide Y or at least one of its subtypes is formed in combination with a zeolite imidazolate framework material. The present invention also discloses a preparation method of the anticancer drug compound, which includes the following steps: 1) dissolving zinc source, 2-imidazole formaldehyde and anticancer active components in solvents respectively to obtain three kinds of solutions ; 2) centrifuge the three solutions in step 1), and dry; 3) disperse the dried product in step 2) in a solvent, add neuropeptide Y or at least one of its subtypes, and stir Reaction 12-72h. The present invention also discloses the application of the anti-cancer drug complex in the preparation of drugs for treating cancer, preferably, the cancer includes breast cancer with high expression of neuropeptide Y1 receptor and breast cancer with high metastases.

Description

technical field [0001] The application relates to an anticancer drug compound and its preparation method and application, belonging to the field of biotechnology. Background technique [0002] The metal-organic framework structure is a material formed by a metal and an organic substance through a weak coordination bond developed in 1990, and it is also called a "metal sponge". Its various structures provide metal-organic frameworks with different morphologies, compositions, sizes, and chemical properties, and also endow them with multifunctionality and stimuli-responsive drug-controlled release. Organometallic frameworks can still maintain controllable size, shape, and high uniformity while these modifications are performed. In addition, its large specific surface area and high porosity also contribute to the loading capacity of this material. In addition, the weakly coordinated bonds that form the metal-organic framework structure also exhibit biodegradability. In short,...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K45/00A61K47/22A61K9/50A61K31/704A61P35/00A61P35/04A61P15/14
Inventor 李娟蒋振奇吴爱国王胤杰袁博房倩兰李彦莹
Owner NINGBO INST OF MATERIALS TECH & ENG CHINESE ACADEMY OF SCI